ZOLL MEDICAL CORPORATION - Key Persons

Job Titles:

• Chief Legal Officer
• Member of the Management Team

Mr. Grossman, who joined ZOLL in 2011, leads the company's Legal Department, which includes corporate and divisional legal teams, as well as Compliance, Privacy and Governance, and Intellectual Property. In this role, he is responsible for managing all aspects of the company's legal function, including mergers and acquisitions, commercial contracts, employment, corporate governance, intellectual property, and litigation. Prior to ZOLL, he served in a similar capacity at LeMaitre Vascular, Inc., a publicly traded medical device company based in Burlington, Mass., with operations in 15 countries. Earlier, from 1999 to 2002, Mr. Grossman was a Corporate Attorney at Goulston & Storrs in Boston. He received a bachelor's degree in political science from Vassar College, a master's degree in law and diplomacy from the Fletcher School of Law and Diplomacy at Tufts University, and a juris doctor degree from Harvard Law School.

Job Titles:

• Member of the Data Management Team

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 46,000 employees around the world, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit www.asahi-kasei.com/sustainability/.

Job Titles:

• Member of the Management Team
• President, ZOLL Respicardia

Prior to being named President of ZOLL Respicardia in 2022, Mr. Anderson spent four years as Vice President of Marketing and Market Access for Respicardia. In that role, he served as the commercial lead for marketing, reimbursement, medical education, physician training, and sales operations, and led the go-to-market strategy for Respicardia's rem edē® System. Prior to joining Respicardia, Mr. Anderson spent 15 years at Boston Scientific in a variety of leadership roles focused on global marketing, strategic and tactical planning, channel strategies, and product management. He holds an MBA from the Tuck School of Business at Dartmouth College, and a bachelor's degree in engineering from North Dakota State University.

Job Titles:

• Chief Financial Officer
• Member of the Management Team

Mr. Stowell was named Chief Financial Officer in 2022 after serving as Vice President, Corporate Controller since 2013. He joined the company in 2003, serving in various finance roles, including planning and budgeting, business development, and corporate governance. Prior to ZOLL, Mr. Stowell was employed by Narad Networks, an early-stage technology company. Earlier, he was an Audit Manager at Deloitte & Touche LLP in Boston. He received a bachelor's degree in accounting from the University of Massachusetts and subsequently earned his CPA license.

Job Titles:

• Member of the Management Team
• President, ZOLL Acute Care Technology

Mr. White was named President of the ZOLL Acute Care Technology division in April 2024, after serving as President of ZOLL Resuscitation for more than five years. He joined ZOLL as Vice President of Marketing in 2012 with responsibilities for the global marketing and strategy of the company's resuscitation portfolio. Prior to ZOLL, Mr. White led North American marketing efforts at Haemonetics. Earlier, he held general management and marketing leadership positions at Orthofix and Medtronic cardiology. Mr. White has also served as a submarine officer in the U.S. Navy and holds an MBA and a B.A. from Harvard University.

Job Titles:

• Member of the Management Team
• President of ZOLL Itamar

Mr. Knudsen became President of ZOLL Itamar in 2022, after leading ZOLL's Corporate Development efforts - including the company's strategic investments and M&A activities - for six years. Prior to joining ZOLL in 2013, Mr. Knudsen held leadership positions in Corporate and Business Development, Marketing, and Sales at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He earned his National EMS Certification and is a licensed EMT in Massachusetts. Mr. Knudsen holds an MBA from the Thunderbird School of Global Management and bachelor's degrees in both Political Science and Communications from Boston College.

Job Titles:

• Member of the Management Team
• Vice President, Corporate Development and Strategy

Ms. Landis is responsible for identifying, assessing, and negotiating opportunities to expand ZOLL's global portfolio of businesses. In this role, she leads ZOLL's early-stage venture investment and M&A activities, as well as ZOLL's short- and long-term growth planning. Prior to joining ZOLL in 2016, Ms. Landis served in leadership positions in corporate development, management consulting, venture capital and public equity direct investing, all with a focus on the medical device industry. She holds an MBA from Babson's Olin School of Business and a bachelor's degree in Political Science from Emory University.

Job Titles:

• Chief Executive Officer
• Member of the Management Team

Mr. Rennert was named Chief Executive Officer of ZOLL in April 2016. Since joining ZOLL in 2008 as President, he has led the company to become the global leader in external defibrillation, diversified the product portfolio through the addition of transport ventilators and intrathoracic pressure regulation (IPR) therapy, and overseen the establishment of Asahi Kasei ZOLL Medical, ZOLL's Japanese subsidiary. Prior to joining ZOLL, Mr. Rennert led the analytical instruments business at PerkinElmer, Inc., and earlier in his career, held manufacturing and engineering leadership positions with United Technologies and General Electric. Mr. Rennert holds master's degrees in management and mechanical engineering from the Massachusetts Institute of Technology (MIT) and a bachelor's degree in mechanical and aerospace engineering from Princeton University.

Job Titles:

• Member of the Management Team
• Vice President, Corporate Human Resources

Ms. Hersey leads ZOLL's global Human Resources organization, which includes Employee Compensation and Benefits, HR Information Systems, Learning and Development, Employee Communications, and Corporate Events. Before joining ZOLL in 2018, Ms. Hersey served in senior leadership roles in Human Resources at TD Bank; Fidelity Investments; and Cigna, a global healthcare company. She holds a juris doctor degree from the Western New England University School of Law and a bachelor's degree in English from the University of Connecticut.

Job Titles:

• Member of the Management Team
• President of the Cardiac Management Solutions
• President, ZOLL Cardiac Management Solutions

Mr. Blastick joined ZOLL as President of the Cardiac Management Solutions division in April 2024. Prior to joining ZOLL, Mr. Blastick was President of Aesculap, a B. Braun Company. From 2006 to 2021, he worked in a variety of executive roles at Boston Scientific. Mr. Blastick holds an MBA from the Kellogg School of Management at Northwestern University and a bachelor's degree in Accounting from Indiana University.

Job Titles:

• Distributor & NBD Manager

Job Titles:

• Management Team

Paul M. Zoll was born and educated in Boston. He attended Harvard Medical School and trained and practiced at the Beth Israel Hospital in Boston for the remainder of his career. During the Second World War, he and Dwight Harken described the operative removal of foreign bodies, shrapnel, bullets, and other metallic objects from within and about the heart and great vessels. These publications demonstrated the ability to successfully operate on the heart, an intervention that had previously been done infrequently. In 1950, a presentation at a meeting of the American College of Surgeons, in Boston, about stimulating the sino-atrial node via a transvenous catheter, inspired Zoll to develop a technique for pacing the heart through the intact chest during asystole. With an epochal publication in 1952 he described cardiac resuscitation via electrodes on the bare chest with 2-millisecond duration pulses of 100-150 volts across the chest, at 60 stimuli per minute. This initial clinical description launched widespread evaluation of pacing and the recognition by the medical profession and the public that the asystolic heart could be stimulated to beat; it became the basis for future clinical pacing developments. This technique eventually fell from favor, except in an emergency, because of associated pain and the limited mobility it allowed the patient. It was later revised using larger skin electrodes and longer pulse durations, both of which made the shocks less painful and therefore more acceptable. In 1955, Zoll described a mechanical technique for "stimulating" the asystolic heart. In 1956, he published a transcutaneous approach to terminate ventricular fibrillation with a much larger shock, of up to 750 volts, and later described similar termination of ventricular tachycardia. His use of an alternating current shock began clinical cardioversion-defibrillation but eventually was replaced by direct current shock, largely for technical reasons. He eventually became an advocate of patient monitoring in the coronary care unit during periods of increased vulnerability. The first such monitoring facilities used equipment manufactured by the Electrodyne Company, with which he had been long associated. He was briefly involved in the development of a pacemaker to be implanted by thoracotomy, but he and Electrodyne soon ceased its manufacture. He participated in the development of emergency pacing and defibrillation throughout his lifetime, but did not participate in the later development of implantable cardiac pacing or implantable cardioversion-defibrillation, both of which benefited from his repetitive pioneering efforts. Zoll was a practicing physician throughout his life with a reputation for careful and dedicated attention to his patients, many of whom he served for decades, all simultaneous with his groundbreaking research in bradycardia and tachycardia control. He was awarded the Lasker Award in 1973 and recognized as a Pioneer in Cardiac Pacing by the North American Society of Pacing and Electrophysiology (NASPE) in 1989. In 1980, Zoll cofounded ZOLL Medical. His seminal work in electrophysiology, internal and external defibrillation, cardioversion, and external pacing provided the foundation for the company. More than 30 years later, the company culture remains focused on new technology and improvements in care provided by that technology in the tradition of the company's namesake.

Job Titles:

• Chairman
• Member of the Management Team

Mr. Packer was appointed Chairman of ZOLL® in April 2016, after serving as Chief Executive Officer since 1999, and earlier as the company's President. He previously held the executive positions of Chief Financial Officer, interim Vice President of North American Sales, and Vice President of Operations. Prior to joining ZOLL in 1992, he was a Vice President at Whistler Corporation, a consumer electronics company. Mr. Packer holds an MBA from the Harvard Business School, as well as an engineering degree from Rensselaer Polytechnic Institute. As of April 2016, Mr. Packer also serves as Executive Officer of Asahi Kasei's Health Care Business Unit.

Job Titles:

• Area Manager

Job Titles:

• Service and Customer Satisfaction Manager Coverage Map

We are pleased to provide on-site service through our Precision and Worry-Free ExpertCare Service Programs. Please click on your state below to access the contact information for the regional Field Service Manager.